SREBF1 and hepatocellular carcinoma: Fatty acid synthetase (FASN) is a key enzyme in cellular de novo fatty acid (FA) synthesis, highly expressing in HCC samples (11), and is transcriptionally activated by its upstream transcription factor liver X receptor (LXR) as well as sterol regulatory element binding protein 1 (SREBP1) (12).